Upvote
Downvote
Oncology Territory Manager, Northeast
Share Job
- Suggest Revision
Full-time
- Enabled by our proprietary drug discovery platform, Deciphera has developed a diverse pipeline of wholly-owned drug candidates.
- QINLOCK (ripretinib) is Deciphera’s switch control inhibitor developed for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Switzerland, Taiwan, the United States, and the United Kingdom.
- Success in this role will require:Partnering with cross-functional commercial partners such as market access and medical teams to provide comprehensive solutions for customers.
- Becoming a true subject matter expert on all key topics that impact the success of the business – GIST and TGCT disease state knowledge, clinical acumen, product expertise, competitive intelligence, market dynamics, customer needs across segments, local market access, etc.
- Using data to continually evaluate plans and pivot as necessary to address evolving landscape and business dynamicsPartner effectively across field and home office teams to create a seamless experience for providers and their patients within the geographyProvide feedback and contribute to the creation of resources, tools, and processes critical to field successContinuously review, evaluate and recommend improvements to the organization to enable higher performance and enhanced patient services
Active Job
Updated TodaySimilar Job
Relevance
Active